Evidence map›Paper›PMID 38746951›Full record

ArticleOpen forum infectious diseases2024

Risk Factors for and Outcomes Following Early Acquisition of

Sophie E Nick, Michael E Yarrington, John M Reynolds, Deverick J Anderson, Arthur W Baker

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sophie E NickDuke University School of Medicine, Durham, North Carolina, USA.ORCID https://orcid.org/0000-0002-6823-0422
Michael E YarringtonDivision of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina, USA.ORCID https://orcid.org/0000-0003-3186-1519
John M ReynoldsDivision of Pulmonary, Allergy and Critical Care Medicine, Duke University School of Medicine, Durham, North Carolina, USA.ORCID https://orcid.org/0000-0003-4766-8852
Deverick J AndersonDivision of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina, USA.ORCID https://orcid.org/0000-0001-6882-5496
Arthur W BakerDivision of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina, USA.ORCID https://orcid.org/0000-0002-0914-0291

Funding

Combined Use of Statistical Process Control and Whole Genome Sequencing to Detect and Investigate Nontuberculous Mycobacterial Clusters and OutbreaksK08AI163462 · NIAID · DUKE UNIVERSITY · PI BAKER, ARTHUR W · 2021 to 2025
$942k
NIAID NIH HHS K08 AI163462
6 · The paper itself

Abstract

Background: Lung transplant recipients are at increased risk of Methods: We conducted a retrospective matched case-control study of patients who underwent lung transplant from 1/1/2012 to 12/31/2021 at a single large tertiary care facility. Cases had de novo MABC isolation within 90 days post-transplant. Controls had no positive MABC cultures and were matched 3:1 with cases based on age and transplant date. Recipient demographics and pre-/peri-operative characteristics were analyzed, and a regression model was used to determine independent risk factors for MABC acquisition. We also assessed 1-year post-transplant outcomes, including mortality. Results: Among 1145 lung transplants, we identified 79 cases and 237 matched controls. Post-transplant mechanical ventilation for >48 hours was independently associated with MABC acquisition (adjusted odds ratio, 2.46; 95% CI, 1.29-4.72; Conclusions: In this large case-control study, prolonged post-transplant ventilator duration was associated with early post-lung transplant MABC acquisition, which in turn was associated with increased hospital-days and mortality. Further studies are needed to determine the best strategies for MABC prevention, surveillance, and management.

Indexed as

case–control studyhospital-associated infectionsinfection preventionlung transplantationnontuberculous mycobacteria

Identifiers

PMID38746951
PMCPMC11093398

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.